SEC Form 4 · accession 0001493152-16-010908
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dave Brian Miller
Officer — SVP Marketing
Period of report
Jun 15, 2016
Accepted (ET)
Jun 16, 2016 · 7:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2016 | P | 10,000 | $0.114 | A | 150,000 | D | |
| Common Stock | Jun 15, 2016 | P | 10,000 | $0.12 | A | 160,000 | D | |
| Common Stock | Jun 16, 2016 | P | 10,000 | $0.1144 | A | 170,000 | D | |
| Common Stock | Jun 16, 2016 | P | 10,000 | $0.118 | A | 180,000 | D |
Table II — derivative securities
No Table II lines on this filing.